SUMMARY
The use of unproven CGT-based treatments can be a risk not only to the individuals who receive the product, but also may have broader impact on families and caregivers.
The unproven treatments can adversely affect legitimate studies attempting to develop safe and proven effective new therapies. ISCT urges healthcare providers to review all available information carefully and be alert to common features of unproven interventions to make the best-informed recommendations concerning CGTs and ultimately protect their patients.
A list of organizations that can provide further information is provided below.